Therapeutic effects of Stronger Neo-Minophagen C (SNMC) in patients with chronic liver disease

Hepatology Research

Volumn 16, Issue 2, 2000, Pages 145-154

  Zhang, Lingxia ^a   Cui, Zhenyu ^a   Wang, Baoen ^a  

^a Chinese Medical Association   (China)

Author keywords

Chronic liver disease; Hepatitis B; Therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLOBULIN; NEOMINOPHAGEN C;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER PROTECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0033989082     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(99)00047-9     Document Type: Article

References (10)

1. Tine F., Liberati A., Craxi A., Almasio P., Pagliaro L. Interferon treatment in patients with chronic hepatitis B: a meta-analysis of the published literature. J. Hepatol. 18:1993;154-162.
2. Wong D.K., Cheung A.M., O'Rourke K., Naylor D.C., Detsky A.S., Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann. Intern. Med. 119:1993;312-323.
3. Dienstag J.L., Perrillo R.P., Schiff E.R., Bartholomew M., Vicary C., Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N. Engl. J. Med. 333:1995;1657-1661.
4. Schalm S.W., de Man R.A., Heijtink R.A., Niesters H.G. New nucleoside a nalogues for chronic hepatitis B. J. Hepatol. 22:1995;52-56.
5. Nevens F., Main J., Honkoop P., Tyrrell D.L., Barber J., Sullivan M.T., Fevery J., de Man R.A., Thomas H.C. Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology. 113:1997;1258-1263.
6. Van Rossum T.G.J., Vulto A.G., de Man R.A., Brouwer J.T., Schalm S.W. Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment Pharmacol. Ther. 12:1998;199-205.
7. Yamamoto S., Maekawa Y., Imamura M., Hisajima T. Treatment of hepatitis with the antiallergic drug, Stronger Neo-Minophagen C. Clin. Med. Ped. (Japanese). 13:1958;73-75.
8. Fujisawa K., Watanabe Y., Kimura K. Therapeutic approach to chronic active hepatitis with glycyrrhizin. Asian Med. J. 23:1980;745-756.
9. Suzuki H., Ohta Y., Takino T., Fujisawa K., Hirayama C. Effects of glycyrrhizin on biochemical tests in patients with chronic hepatitis - double blind trial. Asian Med. J. 26:1983;423-438.
10. Pompei R., Flore O., Marccialis M.A., Pani A., Loddo B. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature. 281:1979;689-690.